New York, New York-based Hospital for Special Surgery (HSS) has named primary sports medicine physician Marci A. Goolsby, M.D. and sports medicine surgeon Beth E. Shubin Stein, M.D. co-directors of the HSS Women’s Sports Medicine Center (WSMC).
Goolsby and Shubin Stein New Co-Directors–HSS Women’s Sports Center
1 min read Premium comments
#hospitalforspecialsurgerySecondary#betheshubin#marciagoolsby
Launched in 1997, the WSMC was the first center to concentrate on women and sports medicine. It was co-founded by primary sports medicine physician Lisa R. Callahan, M.D. and sports medicine surgeon Jo A. Hannafin, M.D., Ph.D. Since its inception, Dr. Callahan and Dr. Hannafin have served as the WSMC’s co-directors.
Dr. Callahan and Dr. Hannafin have had notable careers and have played significant roles in sports medicine. Dr. Callahan will continue to practice medicine and actively contribute to the WSMC while also acting as chief medical officer of Madison Square Garden Sports. Dr. Hannafin, while retired from her clinical practice will, per the press release, continue “to be active in the WSMC and as vice chair of the Institutional Review Board at HSS.”
In the press release, Dr. Goolsby commented, “We want to ensure we carry on the legacy and support all of the work that Drs. Callahan and Hannafin have done as true pioneers in our field.” She also explained that she and Dr. Shubin Stein have been working with members of the team to identify “new, impactful goals for the group.”
OTW spoke with Dr. Shubin Stein about WSMC’s new goals: “Some of our goals for the center are to help with the expansion of the services we already offer at the WSMC at all of our office locations.”
Dr. Shubin Stein continued, “In addition, we are hoping to increase the availability of mental health services offered to our patients at the WSMC, and throughout the hospital during this critical time. We also look forward to building a Women’s Health Network that will provide increased services and specialty care for active women throughout HSS.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.